Autoantibody Against Gm-Csf Presented By Mhc Class Ii In Autoimmune Pulmonary Alveolar ProteINOSis

被引：0
|
作者：
Hamano, Y. [1 ]
Kida, H. [1 ]
Hirose, M. [2 ]
Matsumuro, A. [2 ]
Suenaga, T. [3 ]
Sarashina, H. [1 ]
Hamasaki, T. [4 ]
Inoue, Y. [2 ]
Arase, H. [3 ]
Kumanogoh, A. [1 ]
机构：
[1] Osaka Univ, Suita, Osaka, Japan
[2] Natl Hosp Org, Kinki Chuo Chest Med Ctr, Sakai, Osaka, Japan
[3] World Premier Int Res Ctr WPI, Immunol Frontier Res Ctr, Suita, Osaka, Japan
[4] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3147
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Lack of GM-CSF as a cause of pulmonary alveolar proteinosis
    Hallman, M
    Merritt, TA
    JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (03): : 589 - 590
  • [32] Relapsing Pulmonary Alveolar Proteinosis Treated with GM-CSF
    Alkhankan, E.
    Alkhankan, H.
    Bukamur, H. S.
    Amro, A.
    Megri, M. A.
    Alkhankan, F.
    Zeid, F. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [33] Generation of cDNA Library Encoding GM-CSF Autoantibody Sequences in Autoimmune Pulmonary Alveolar Proteinosis by Next Generation Sequencing
    Nakata, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [34] Cross-sectional and longitudinal measurement of autoantibody levels against GM-CSF is useful for predicting clinical courses of in autoimmune pulmonary alveolar proteinosis
    Yamaguchi, Etsuro
    Nishimura, Masaki
    Takahashi, Ayumu
    Tanaka, Hiroshi
    Yokoe, Norihito
    Kosaka, Kenshi
    Yonezawa, Toshiyuki
    Kubo, Akihito
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [35] The Efficacy of GM-CSF Inhalation for Autoimmune Pulmonary Alveolar Proteinosis Is Influenced by Smoking Status
    Kitamura, N.
    Tazawa, R.
    Nakata, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [36] Characteristics Of Negative Gm-Csf Autoantibody Pulmonary Alveolar ProteINOSis (na-Pap) In Japan
    Ishii, H.
    Nakata, K.
    Tazawa, R.
    Inoue, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [37] The Role of GM-CSF Autoantibodies in Infection and Autoimmune Pulmonary Alveolar Proteinosis: A Concise Review
    Ataya, Ali
    Knight, Vijaya
    Carey, Brenna C.
    Lee, Elinor
    Tarling, Elizabeth J.
    Wang, Tisha
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [38] CHARACTERISTICS OF NEGATIVE GM-CSF AUTOANTIBODY PULMONARY ALVEOLAR PROTEINOSIS (NA-PAP) IN JAPAN
    Ishii, H.
    Nakata, K.
    Tazawa, R.
    Inoue, Y.
    RESPIROLOGY, 2012, 17 : 76 - 76
  • [39] IgM-type GM-CSF autoantibody is etiologically a bystander but associated with IgG-type autoantibody production in autoimmune pulmonary alveolar proteinosis
    Nei, Takahito
    Urano, Shinya
    Motoi, Natsuki
    Takizawa, Jun
    Kaneko, Chinatsu
    Kanazawa, Hiroko
    Tazawa, Ryushi
    Nakagaki, Kazuhide
    Akagawa, Kiyoko S.
    Akasaka, Keiichi
    Ichiwata, Toshio
    Azuma, Arata
    Nakata, Koh
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2012, 302 (09) : L959 - L964
  • [40] A Mathematical Model That Estimates The Amount Of Eliminated Gm-Csf Autoantibody By Whole-Lung Lavage In Autoimmune Pulmonary Alveolar ProteINOSis
    Tanaka, T.
    Akasaka, K.
    Maruyama, T.
    Kitamura, N.
    Hashimoto, A.
    Shiiya, K.
    Itoh, Y.
    Ohkouchi, S.
    Tazawa, R.
    Yamaguchi, E.
    Ichiwata, T.
    Hirose, M.
    Arai, T.
    Inoue, Y.
    Kobayashi, H.
    Nakata, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
12345